Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Potential prognostic value of isolated tumour cells in breast cancer sentinel nodes

ECCO 15 - ESMO 34

20 - 24 Sep 2009

Published: 4 Nov 2009

Views: 14145

Rating:

Save

Dr Marjut Leidenius - Breast Surgery Unit, Helsinki University Central Hospital

Dr Marjut Leidenius from the Breast Surgery Unit, Helsinki University Central Hospital discusses her work with the prognostic value of isolated tumour cells in breast cancer sentinel nodes. Speaking at ECCO 15 - ESMO 34, Berlin, 2009.

Related Videos

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Precision oncology: Present and future in breast cancer

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Precision oncology: Present and future in breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Imaging advances for breast surgery

Prof Mehra Golshan - Yale School of Medicine, New Haven, USA

Imaging advances for breast surgery ( Prof Mehra Golshan - Yale School of Medicine, New Haven, USA )

Personalised risk-stratified breast cancer screening for BRCA germline...

Prof Banu Arun - MD Anderson Cancer Center, Houston, USA

Personalised risk-stratified breast cancer screening for BRCA germline mutations and other genes ( Prof Banu Arun - MD Anderson Cancer Center, Houston, USA )

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy...

Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer ( Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA )

Breast-conserving therapy may be option for multiple breast lesions

Dr Judy Boughey - Mayo Clinic, Rochester, USA

Breast-conserving therapy may be option for multiple breast lesions ( Dr Judy Boughey - Mayo Clinic, Rochester, USA )

Treatment decision guided by CTC count may improve long-term outcomes for mBC

Prof Jean-Yves Pierga - Institut Curie, Paris, France

Treatment decision guided by CTC count may improve long-term outcomes for mBC ( Prof Jean-Yves Pierga - Institut Curie, Paris, France )

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan

Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston...

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer